drugset / Trial / NCT03807037

Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation

NCT03807037 ↗

RandomizedParallel-groupTriple-blindPrevention

Summary

This study is a prospective, randomized, controlled trial with parallel groups to assess the effects of tocotrienol in the occurrence of atrial fibrillation (AF) post-CABG.

Timeline

Start
2018-12-17
Primary completion
2021-12-30
Completion
2021-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tocotrienols Unknown 200 mg Oral

Indications